506128 — Parnax Lab Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Parnax Lab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	12.7	57.8	12.8	18.8	26.8
Net Total Accounts Receivable
Net Total Receivables	202	393	314	337	312
Total Inventory
Total Other Current Assets
Total Current Assets	392	748	611	754	683
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	644	752	789	1,093	1,169
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,063	1,535	1,451	1,888	1,898
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	544	810	630	818	743
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	737	1,053	829	1,172	1,067
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	325	482	622	716	831
Total Liabilities & Shareholders' Equity	1,063	1,535	1,451	1,888	1,898
Total Common Shares Outstanding